David Remland, 54, is accused of paying kickbacks so that urine tests at a substance-abuse treatment facility based in New Hampshire would be directed to his Delray Beach lab, according to an arrest report.
Remland allegedly paid $100,000 in kickbacks and faces four counts of patient brokering. He was arrested Monday and released Tuesday from the Palm Beach County Jail after posting a $12,000 bond.
The urine of people who are battling drug addiction and who have health insurance is worth millions of dollars to the operators of labs, sober homes and treatment centers.
A Palm Beach Post investigation found that insurance companies often are billed up to $5,000 for a single urine drug screen. Those with addictions sometimes are tested three or more times per week, and even partial reimbursement from insurance companies can return $1,500 to $2,000 per urine sample.
Under Florida law, it is illegal for a lab or a health-care provider either to offer or to pay a sober home or a drug-treatment center a commission, bonus, or bribe for the referral of patients.
Remland is also facing patient-brokering charges in two other cases connected to Impact Q Testing, his Delray Beach lab.
According to the arrest report, Remland entered into an agreement to pay PTK Enterprise, a business based in suburban Boynton Beach, $50,000 a month so that it would send between 450 and 480 urine samples from Gatehouse Treatment in New Hampshire to Impact Q Testing.
The arrangement lasted two months before Remland and the other owners of Impact Q — Mark Desimone of Boca Raton and Daniel Kandler of suburban Delray Beach — were arrested in May 2017.
Remland has pleaded not guilty to five counts of patient brokering connected to his May 2017 arrest.
Remland also faces two counts of patient brokering and pleaded not guilty after he was arrested May 31 in another alleged kickback scheme. He was released on his own recognizance on those charges with a judge’s stipulation that he not work in the sober-home industry.